XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2022
Stockholders' Equity  
Common Stock Dividends (Table)

For the three months ended

March 31, 

    

2022

    

2021

Dividends declared per common share

$

0.64

  

$

0.56

Reconciliation of Outstanding Common Shares (Table)

For the three months ended

March 31, 

    

2022

    

2021

(in millions)

Beginning balance

 

261.7

 

273.3

Shares issued

 

1.7

 

1.4

Treasury stock acquired

 

(11.2)

 

(2.2)

Ending balance

 

252.2

 

272.5

Other Comprehensive Income (Loss) (Table)

For the three months ended

March 31, 2022

    

Pre-Tax

    

Tax

    

After-Tax

(in millions)

Net unrealized losses on available-for-sale securities during the period

$

(5,542.9)

$

1,175.1

$

(4,367.8)

Reclassification adjustment for gains included in net income (1)

 

(40.6)

5.2

(35.4)

Adjustments for assumed changes in amortization patterns

 

344.9

(72.4)

272.5

Adjustments for assumed changes in policyholder liabilities

 

575.6

(118.8)

456.8

Net unrealized losses on available-for-sale securities

 

(4,663.0)

989.1

(3,673.9)

Net unrealized losses on derivative instruments during the period

 

(21.0)

4.4

(16.6)

Reclassification adjustment for gains included in net income (2)

 

(6.8)

1.4

(5.4)

Adjustments for assumed changes in amortization patterns

 

2.3

(0.5)

1.8

Adjustments for assumed changes in policyholder liabilities

 

5.0

(1.1)

3.9

Net unrealized losses on derivative instruments

(20.5)

4.2

(16.3)

Foreign currency translation adjustment

154.9

(1.5)

153.4

Amortization of amounts included in net periodic benefit cost (3)

 

9.0

(2.3)

6.7

Net unrecognized postretirement benefit obligation

 

9.0

(2.3)

6.7

Other comprehensive loss

$

(4,519.6)

$

989.5

$

(3,530.1)

For the three months ended

March 31, 2021

    

Pre-Tax

    

Tax

    

After-Tax

(in millions)

Net unrealized losses on available-for-sale securities during the period

$

(3,276.7)

$

700.5

$

(2,576.2)

Reclassification adjustment for gains included in net income (1)

 

(27.4)

 

5.7

 

(21.7)

Adjustments for assumed changes in amortization patterns

 

144.6

 

(30.4)

 

114.2

Adjustments for assumed changes in policyholder liabilities

 

1,415.3

 

(305.0)

 

1,110.3

Net unrealized losses on available-for-sale securities

 

(1,744.2)

 

370.8

 

(1,373.4)

Net unrealized gains on derivative instruments during the period

 

0.7

 

(0.1)

 

0.6

Reclassification adjustment for gains included in net income (2)

 

(4.4)

 

0.9

 

(3.5)

Adjustments for assumed changes in policyholder liabilities

 

1.0

 

(0.3)

 

0.7

Net unrealized losses on derivative instruments

 

(2.7)

 

0.5

 

(2.2)

Foreign currency translation adjustment

(56.1)

(0.1)

(56.2)

Unrecognized postretirement benefit obligation during the period

(9.1)

1.9

(7.2)

Amortization of amounts included in net periodic benefit cost (3)

 

13.0

 

(3.5)

 

9.5

Net unrecognized postretirement benefit obligation

 

3.9

 

(1.6)

 

2.3

Other comprehensive loss

$

(1,799.1)

$

369.6

$

(1,429.5)

(1)Pre-tax reclassification adjustments relating to available-for-sale securities are reported in net realized capital gains (losses) on the consolidated statements of operations.
(2)See Note 4, Derivative Financial Instruments, under the caption “Effect of Fair Value and Cash Flow Hedges on Consolidated Statements of Operations” for further details.
(3)Amount is comprised of amortization of prior service cost (benefit) and recognized net actuarial (gain) loss, which is reported in operating expenses on the consolidated statements of operations. See Note 7, Employee and Agent Benefits, under the caption “Components of Net Periodic Benefit Cost” for further details.
Accumulated Other Comprehensive Income (Loss) (Table)

Net unrealized

Net unrealized

Foreign

Unrecognized

Accumulated

gains (losses) on

gains

currency

postretirement

other

available-for-sale

on derivative

translation

benefit

comprehensive

    

securities (1)

    

instruments

    

adjustment

    

obligation

    

income (loss)

(in millions)

Balances as of January 1, 2021

$

4,138.3

$

18.2

$

(1,312.9)

$

(460.5)

$

2,383.1

Other comprehensive loss during the period, net of adjustments

 

(1,351.7)

1.3

(56.0)

(7.2)

(1,413.6)

Amounts reclassified to AOCI

 

(21.7)

(3.5)

9.5

(15.7)

Other comprehensive loss

 

(1,373.4)

(2.2)

(56.0)

2.3

(1,429.3)

Balances as of March 31, 2021

$

2,764.9

$

16.0

$

(1,368.9)

$

(458.2)

$

953.8

Balances as of January 1, 2022

$

3,467.4

$

51.8

$

(1,563.6)

$

(344.7)

$

1,610.9

Other comprehensive loss during the period, net of adjustments

 

(3,638.5)

(10.9)

152.0

(3,497.4)

Amounts reclassified to AOCI

 

(35.4)

(5.4)

6.7

(34.1)

Other comprehensive loss

 

(3,673.9)

(16.3)

152.0

6.7

(3,531.5)

Balances as of March 31, 2022

$

(206.5)

$

35.5

$

(1,411.6)

$

(338.0)

$

(1,920.6)

(1)Net unrealized gains (losses) on available-for-sale securities for which an allowance for credit loss has been recorded were $6.2 million and $(2.4) million as of March 31, 2022 and 2021, respectively.
Redeemable Noncontrolling Interest (Table)

For the three months ended

March 31, 

2022

2021

(in millions)

Balance at beginning of period

$

332.5

$

255.6

Net loss attributable to redeemable noncontrolling interest

(10.3)

(1.8)

Contributions from redeemable noncontrolling interest

24.0

17.8

Distributions to redeemable noncontrolling interest

(39.6)

(16.3)

Change in redemption value of redeemable noncontrolling interest

0.1

8.2

Other comprehensive income attributable to redeemable noncontrolling interest

0.1

Balance at end of period

$

306.8

$

263.5